News

A special issue of the journal Vaccine, guest-edited by WHO and published today, focuses on the research and development (R&D) pipeline of vaccines against 25 pathogens for which no licensed vaccines currently exists but for which there is high public health importance, as identified by the WHO Product Development for Vaccines Advisory Committee (PDVAC).

...  Rapid Progress on New Technologies for Neglected Diseases

GHIT’s projects have progressed quickly in three years thanks to just such a scale-up in projects run by global collaborations.  In fact, just in the last year, four progressed to clinical trials:

On 21 January French Clinical Research Infrastructure Network (F-CRIN) organised the first full day meeting (programme) at Institut Pasteur with the health industry.  The meeting was a forum for a valuable mutual exchange of expertise with F-CRIN's clinical research.

Relevant video and presentations

The following publication relating to the EVI coordinated and EC funded EMVDA project: Immunogenicity of diamorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice, was recently published in Vaccine

The abstract is also available on this web site under publications.

The following products are now available on the The National Institute for Biological Standards and Control (NIBSC) website:

Influenza Virus Infectious NYMC BX-35 41950 E11 (Influenza Reagent)19-05-2016 01:00 AM BST 15/300

The presentations given at the captioned forum 15 - 17 March 2016 in Johannesburg are now available.

The following new publication relating to the EVI coordinated and EDCTP funded MVVC project:  Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants, has just been published in Mol Ther.

The abstract is also available on this web site under publications

The first publication relating to the EC funded BELLEROPHON project, in which EVI is a partner, has been published in Vaccine

The abstract is also available on this web site under publications

Listed below is a list of the products now available on the The National Institute for Biological Standards and Control (NIBSC) web site.

Call for Nominations

Sanofi and the Institut Pasteur are pleased to announce the Sanofi - Institut Pasteur 2016 Awards.

These Awards will honor and support four scientists, whose outstanding research shows real progress in the life sciences that contributes to global public health, specifically in the following fields:

Tropical and neglected diseases  Immunology  Drug resistance  Neuroscience